Zhendan Yao
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
The length of negative proximal resection margin does not significantly influence on the prognosis of Siewert type II adenocarcinoma of esophagogastric junction with or without neoadjuvant chemotherapy.
Journal: Frontiers in oncology
Published: January 02, 2026
Effect of anastomotic reinforcement with barded suture on anastomotic leakage prevention following laparoscopic low anterior resection for rectal cancer: a retrospective single-center study.
Journal: BMC surgery
Published: September 06, 2024
Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study.
Journal: Surgical endoscopy
Published: February 26, 2024
Clinicopathological characteristics and treatment outcome of resectable gastric cancer patients with small para-aortic lymph node.
Journal: Frontiers in oncology
Published: December 26, 2022
Neutrophil-to-Lymphocyte Ratio as an Early Predictor of Symptomatic Anastomotic Leakage in Patients after Rectal Cancer Surgery: A Propensity Score-Matched Analysis.
Journal: Journal of personalized medicine
Published: December 06, 2022
Effect of lateral lymph nodes without malignant characteristics on the prognosis of patients with rectal cancer.
Journal: Future oncology (London, England)
Published: November 01, 2022
Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy.
Journal: Frontiers in oncology
Published: October 26, 2022
Patterns and predictors of recurrence after laparoscopic resection of rectal cancer.
Journal: Frontiers in oncology
Published: September 02, 2022
Modified π-shaped esophagojejunostomy in totally laparoscopic total gastrectomy: a report of 40 consecutive cases from a single center.
Journal: The Journal of international medical research
Published: August 19, 2022
The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study.
Journal: BMC cancer
Published: June 03, 2022
Health-Related Quality of Life in Patients With Locally Advanced Gastric Cancer Undergoing Perioperative or Postoperative Adjuvant S-1 Plus Oxaliplatin With D2 Gastrectomy: A Propensity Score-Matched Cohort Study.
Journal: Frontiers in oncology
Published: January 12, 2022
Last Updated: 09/26/2026